Physician profile
Jongoh Kim
NPI 1114181591
$9,331.55
in general payments reported to CMS, 2019-2025
49 companies · $2,994 in 2025
The $2,994 reported for 2025 was more than what 83% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.90 · 2020: $540 · 2021: $1,052 · 2022: $1,175 · 2023: $1,068 · 2024: $2,489 · 2025: $2,994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,534 · Entertainment: $16.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,533.80 |
| Entertainment | $16.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $834.54 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $770.23 | 2020-2025 | |
| Corcept Therapeutics | $693.32 | 2020-2025 | Korlym |
| Lilly USA, LLC | $608.76 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $560.18 | 2021-2025 | Tepezza, Evenity, Repatha |
| Tandem Diabetes Care, INC. | $533.47 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $499.12 | 2020-2025 | Jardiance |
| Insulet Corporation | $467.69 | 2024-2025 | Omnipod |
| Abbott Laboratories | $405.21 | 2022-2025 | Freestyle Libre, Proclaim |
| Mannkind Corporation | $370.27 | 2020-2022 | |
| Xeris Pharmaceuticals, INC. | $353.86 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Abbvie INC. | $307.48 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $275.33 | 2020-2024 | Farxiga, Lokelma |
| Medtronic, INC. | $256.83 | 2022-2024 | Minimed 780g, Intellis Adaptivestim |
| Dexcom, INC. | $225.87 | 2021-2025 | Dexcom G6 Transmitter |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $184.19 | 2023-2025 | Isturisa, Signifor Lar |
| Ascendis Pharma Endocrinology INC | $181.97 | 2025 | Yorvipath |
| Radius Health, INC. | $175.79 | 2024-2025 | Tymlos |
| Beta Bionics, INC. | $137.88 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Bayer Healthcare Pharmaceuticals INC. | $121.77 | 2023-2025 | |
| Amneal Pharmaceuticals LLC | $109.96 | 2021-2025 | Unithroid |
| Neurocrine Biosciences, INC. | $99.53 | 2025 | |
| Alexion Pharmaceuticals, INC. | $95.50 | 2022-2025 | Strensiq |
| Cequr Corporation | $86.81 | 2022-2025 | Cequr Simplicity |
| Kyowa Kirin, INC. | $81.17 | 2024-2025 | Crysvita |
| Ultragenyx Pharmaceutical INC. | $80.59 | 2020-2024 | Crysvita, Crysvita |
| Madrigal Pharmaceuticals | $75.67 | 2025 | Rezdiffra |
| Ibsa Pharma INC. | $63.38 | 2021-2024 | Tirosint, Licart, Licart |
| Avvisto Therapeutics, LLC | $60.71 | 2025 | Cycloset |
| Embecta Corp. | $60.56 | 2024 | Bd Nano 2nd Gen Pen Needle |
| Horizon Therapeutics Plc | $57.73 | 2021-2023 | Tepezza |
| Nevro Corp. | $55.87 | 2023 | Senza |
| Pfizer INC. | $47.53 | 2022-2024 | |
| Tolmar, INC. | $41.01 | 2025 | Jatenzo |
| Sequel Med Tech, LLC | $36.86 | 2025 | Twiist |
| Ascensia Diabetes Care US INC. | $33.80 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.70 | 2022-2023 | Cycloset |
| Rhythm Pharmaceuticals, INC. | $29.62 | 2025 | Imcivree |
| Theracosbio, LLC | $29.03 | 2023-2024 | Brenzavvy |
| Sandoz INC. | $26.62 | 2025 | |
| Glaxosmithkline, LLC. | $22.87 | 2025 | Shingrix |
| Echosens North America, INC. | $21.18 | 2022 | |
| Acella Pharmaceuticals, LLC | $18.97 | 2025 | NP Thyroid 60 |
| Janssen Pharmaceuticals, INC | $18.59 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $18.33 | 2022 | |
| Intra-Sana Laboratories | $17.19 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Optos, INC. | $16.71 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Evoke Pharma, INC. | $15.62 | 2025 | |
| Novartis Pharmaceuticals Corporation | $12.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jongoh Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.